Bora CDMO Bora CDMO

X

Find the latest Drugs in Development and Pipeline Prospector News of SutroVax.

  • Webinars & Exhibitions

PharmaCompass
Send me more info on How To Grow My Bussiness Digitally?
SutroVax
United_States_of_America Flag
Country
Country
U.S.A
Address
Address
SutroVax, Inc. 353 Hatch Drive Foster City, CA 94404
Telephone
Telephone
(650) 837-0111
Linkedin
Linkedin
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Details:

SutroVax has generated preclinical proof of concept versus the standard of care vaccines and intends to advance SVX-XP into the clinic as a future successor to SVX-24.


Lead Product(s): SVX-24

Therapeutic Area: Pulmonary/Respiratory Diseases Product Name: Undisclosed

Highest Development Status: PreclinicalProduct Type: Vaccine

Partner/Sponsor/Collaborator: RA Capital Management

Deal Size: $110.0 million Upfront Cash: Undisclosed

Deal Type: Series D Financing March 26, 2020

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY